EU-V: U32 Offizielles Ratsdokument
COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS EU STRATEGY ON COVID-19 THERAPEUTICS
Erstellt am 07.05.2021 von: Beschäftigung, Sozialpolitik und Gesundheit
Eingelangt am 25.05.2021, U32 Übermittlung
- RAT: 8545/21 PDF
| Linkart | Link |
|---|---|
| COM
|
COM(2020) 245 |
| COM
|
COM(2020) 761 |
| COM
|
COM(2021) 350 |
| COM
|
COM(2021) 355 |
| COM
|
COM(2021) 78 |
| COM
|
C(2020) 3200 |
| COM
|
SWD(2021) 352 |
| RMA
|
DEVGEN 87 |
| RMA
|
MI 321 |
| RMA
|
PHARM 77 |
| RMA
|
RECH 195 |
| RMA
|
SAN 275 |
| ABL
|
OJ L 107, 26.3.2021, p. 1 |
| ABL
|
OJ L 158, 27.5.2014, p. 1 |
| RIL
|
2001/20/EC |
| RIL
|
2014/24/EU |
| VER
|
2021/52 |
| VER
|
282/2014 |
| VER
|
536/2014 |
| Code | Sachgebiet |
|---|---|
| SAN 275 | Gesundheit |
| PHARM 77 | Pharmazie |
| MI 321 | Binnenmarkt |
| DEVGEN 87 | Entwicklung (Allgemein) |
| RECH 195 | Forschung (Allgemein) |
| DIGIT 55 | Digitale Inhalte |
| COVID-19 189 | COVID-19 |